5 reports

  • INSULIN DELIVERY DEVICES MARKET, BY TYPE
  • INSULIN DELIVERY DEVICES MARKET, BY REGION

The insulin delivery devices market is projected to reach USD 17.85 billion by 2021 from USD 11.54 billion in 2016, growing at a CAGR of 9.1% in the next five years (2016 to 2021). Favorable reimbursement scenario and strong government support in selected countries, technological advancements in insulin delivery devices, growing diabetic...

  • Diabetes
  • Injectable Delivery
  • Insulin Delivery
  • Animas Corporation
  • Ypsomed AG
  • INSULIN DELIVERY DEVICES MARKET, BY REGION
  • INSULIN DELIVERY DEVICES MARKET, BY TYPE

The insulin delivery devices market is projected to reach USD 17.85 billion by 2021 from USD 11.54 billion in 2016, growing at a CAGR of 9.1% in the next five years (2016 to 2021). Favorable reimbursement scenario and strong government support in selected countries, technological advancements in insulin delivery devices, growing diabetic...

  • Diabetes
  • Injectable Delivery
  • Insulin Delivery
  • Animas Corporation
  • Ypsomed AG
  • Insulin Delivery Market, BRIC
  • Insulin Delivery Market, Russia

BRIC Insulin Delivery Market Outlook to 2022 Summary GlobalData’s new report, "BRIC Insulin Delivery Market Outlook to 2022", provides key market data on the BRIC Insulin Delivery market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Insulin Pens,...

  • Healthcare
  • Insulin Delivery
  • Medical Device
  • Eli Lilly & Co.
  • Ypsomed AG
  • Ypsomed Holding AG Pipeline Products by Equipment Type
  • LANZI - PRODUCT STATUS

Summary Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures injection and infusion systems for self-medication and offers related services.It offers autoinjectors, dual chamber pens, and pen injectors. The company also offers services ranging from design and development...

  • Insulin Delivery
  • United States
  • Company Financials
  • Supply
  • Ypsomed AG

The company competes with Novo Nordisk, Eli Lilly and Sanofi in the Insulin delivery market; Roche, Johnson & Johnson, Bayer and Abbott in the blood glucose monitoring systems; and Medtronic, Roche and Johnson & Johnson in the insulin pump market.

  • Insulin Delivery
  • Germany
  • United States
  • Company Financials
  • Ypsomed AG